Construction of Fosmid-based SARS-CoV-2 replicons for antiviral drug screening and replication analyses in biosafety level 2 facilities.

Takazawa S, Kotaki T, Nakamura S, Utsubo C, Kameoka M

Open source

DOI
10.1016/j.virusres.2023.199176
Published
2023 Sep
Container
Virus research
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.virusres.2023.199176,
  title = {Construction of Fosmid-based SARS-CoV-2 replicons for antiviral drug screening and replication analyses in biosafety level 2 facilities.},
  author = {Takazawa S and Kotaki T and Nakamura S and Utsubo C and Kameoka M},
  year = {2023},
  journal = {Virus research},
  doi = {10.1016/j.virusres.2023.199176},
  url = {https://doi.org/10.1016/j.virusres.2023.199176}
}

RIS

TY  - JOUR
TI  - Construction of Fosmid-based SARS-CoV-2 replicons for antiviral drug screening and replication analyses in biosafety level 2 facilities.
AU  - Takazawa S
AU  - Kotaki T
AU  - Nakamura S
AU  - Utsubo C
AU  - Kameoka M
PY  - 2023
JO  - Virus research
DO  - 10.1016/j.virusres.2023.199176
UR  - https://doi.org/10.1016/j.virusres.2023.199176
ER  - 

APA

S, T., T, K., S, N., C, U., & M, K. (2023). Construction of Fosmid-based SARS-CoV-2 replicons for antiviral drug screening and replication analyses in biosafety level 2 facilities.. Virus research. https://doi.org/10.1016/j.virusres.2023.199176

Source records